A series of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidines derivatives were synthesized using a convenient synthetic route. We evaluate the isosteric replacement of methyl groups in 4-(2-methylimidazo[1,2-a]pyridin-3-yl)-N-p-tolylpyrimidin-2-amine (compound 1) by trifluoromethyl groups and the isosteric substitution of the 2-methylimidazo[1,2-a]pyridin-3-yl scaffold by quinolin-4-yl or quinolin-3-yl moieties. The replacement of hydrogen by fluorine does not affect notably the cytotoxic activity and CDK inhibitor activity in this series. Quinolin-4-yl-substituted compound, 8, presents cytotoxic activity and is most effective and selective against CDK1/CycA than against CDK2/CycB. Compound 11, which has a quinolin-3-yl moiety is CDK inhibitor but presents null cytotoxic activity. Quinolin-4-yl-substituted compounds constitute a new lead of cytotoxic and CDK inhibitor compounds from which more compelling and selective inhibitors can be designed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2009.10.002DOI Listing

Publication Analysis

Top Keywords

cytotoxic activity
16
cdk inhibitor
12
2-methylimidazo[12-a]pyridine- quinoline-substituted
8
activity
5
synthesis cytotoxic
4
activity 2-methylimidazo[12-a]pyridine-
4
quinoline-substituted 2-aminopyrimidine
4
2-aminopyrimidine derivatives
4
derivatives series
4
series 2-methylimidazo[12-a]pyridine-
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!